Adaptive responses induced by 24S-hydroxycholesterol through liver X receptor pathway reduce 7-ketocholesterol-caused neuronal cell death

Redox Biology

Volumn 2, Issue 1, 2014, Pages 28-35

  Okabe, Akishi ^a   Urano, Yasuomi ^a   Itoh, Sayoko ^a   Suda, Naoto ^a   Kotani, Rina ^a   Nishimura, Yuki ^a   Saito, Yoshiro ^a   Noguchi, Noriko ^a  

^a DOSHISHA UNIVERSITY   (Japan)

Author keywords

24S hydroxycholesterol; 7 ketocholesterol; Adaptive responses; ATP binding cassette transporter G1; Cell death; Liver X receptor

Indexed keywords

24S HYDROXYCHOLESTEROL; ABC TRANSPORTER A1; ABC TRANSPORTER G1; CHOLESTEROL DERIVATIVE; LIVER X RECEPTOR; UNCLASSIFIED DRUG; 24 HYDROXYCHOLESTEROL; 25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 7 OXOCHOLESTEROL; ALITRETINOIN; LIVER X RECEPTOR BETA; 24-HYDROXYCHOLESTEROL; 7-KETOCHOLESTEROL; ABC TRANSPORTER; ABCA1 PROTEIN, HUMAN; ABCG1 PROTEIN, HUMAN; ORPHAN NUCLEAR RECEPTOR; SMALL INTERFERING RNA;

ABCA1 GENE; ABCG1 GENE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; NEUROBLASTOMA; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; CELL VIABILITY; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION; NERVE CELL DIFFERENTIATION; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; NERVE CELL; RNA INTERFERENCE; TUMOR CELL LINE; UPREGULATION;

APOPTOSIS; ATP BINDING CASSETTE TRANSPORTER 1; ATP-BINDING CASSETTE TRANSPORTERS; CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; HYDROXYCHOLESTEROLS; KETOCHOLESTEROLS; NEURONS; ORPHAN NUCLEAR RECEPTORS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84890826882     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.11.007     Document Type: Article

References (43)

1. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2007, Clarendon, Oxford, UK. fourth ed.
2. Chung H.S., Wang S.B., Venkatraman V., Murray C.I., Van Eyk J.E. Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circ. Res. 2013, 112:382-392.
3. Sultana R., Butterfield D.A. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies. J. Alzheimers Dis. 2013, 33(Suppl. 1):S243-S251.
4. Il'yasova D., Scarbrough P., Spasojevic I. Urinary biomarkers of oxidative status. Clin. Chim. Acta 2012, 413:1446-1453.
5. Jungnickel H., Tentschert J., Luch A. Monitoring oxidative stress biomarkers in the lipidome: is there a roadmap for "human inspection"?. Curr. Mol. Med. 2012, 12:716-731.
6. Yoshida Y., Niki E. Bio-markers of lipid peroxidation in vivo: hydroxyoctadecadienoic acid and hydroxycholesterol. Biofactors 2006, 27:195-202.
7. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic. Biol. Med. 2009, 47:469-484.
8. Murphy R.C., Johnson K.M. Cholesterol, reactive oxygen species, and the formation of biologically active mediators. J. Biol. Chem. 2008, 283:15521-15525.
9. Björkhem I. Five decades with oxysterols. Biochimie 2013, 95:448-454.
10. Olkkonen V.M. Macrophage oxysterols and their binding proteins: roles in atherosclerosis. Curr. Opin. Lipidol. 2012, 23:462-470.
11. Simonian N.A., Coyle J.T. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 1996, 36:83-106.
12. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 2003, 53(Suppl. 3):S26-S36.
13. Russell D.W., Halford R.W., Ramirez D.M., Shah R., Kotti T. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain. Annu. Rev. Biochem. 2009, 78:1017-1040.
14. Rao M.L., Lütjohann D., Ludwig M., Kölsch H. Induction of apoptosis and necrosis in human neuroblastoma cells by cholesterol oxides. Ann. N. Y. Acad. Sci. 1999, 893:379-381.
15. Kim D.E., Youn Y.C., Kim Y.K., Hong K.M., Lee C.S. Glycyrrhizin prevents 7-ketocholesterol toxicity against differentiated PC12 cells by suppressing mitochondrial membrane permeability change. Neurochem. Res. 2009, 34:1433-1442.
16. Jang E.R., Lee C.S. 7-ketocholesterol induces apoptosis in differentiated PC12 cells via reactive oxygen species-dependent activation of NF-κB and Akt pathways. Neurochem. Int. 2011, 58:52-59.
17. Lütjohann D., Breuer O., Ahlborg G., Nennesmo I., Sidén A., Diczfalusy U., Björkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. USA 1996, 93:9799-9804.
18. Lund E.G., Guileyardo J.M., Russell D.W. cDNA cloning of cholesterol 24-hydroxylase, a regulator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA 1999, 96:7238-7243.
19. 2 techniques in vivo and in vitro. J. Biol. Chem. 1997, 272:30178-30184.
20. Jeitner T.M., Voloshyna I., Reiss A.B. Oxysterol derivatives of cholesterol in neurodegenerative disorders. Curr. Med. Chem. 2011, 18:1515-1525.
21. Heverin M., Bogdanovic N., Lutjohann D., Bayer T., Pikuleva I., Bretillon L., Diczfalusy U., Winblad B., Bjorkhem I. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 2004, 45:186-193.
22. Lütjohann D., Papassotiropoulos A., Björkhem I., Locatelli S., Bagli M., Oehring R.D., Schlegel U., Jessen F., Rao M.L., von Bergmann K., Heun R. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 2000, 41:195-198.
23. Kölsch H., Lütjohann D., Tulke A., Björkhem I., Rao M.L. The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. Brain Res. 1999, 818:171-175.
24. Yamanaka K., Saito Y., Yamamori T., Urano Y., Noguchi N. 24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis. J. Biol. Chem. 2011, 286:24666-24673.
25. Urano Y., Ochiai S., Noguchi N. Suppression of amyloid-beta production by 24S-hydroxycholesterol via inhibition of intracellular amyloid precursor protein trafficking. FASEB J. 2013, 27:4305-4315.
26. Chen Z.H., Saito Y., Yoshida Y., Sekine A., Noguchi N., Niki E. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via transcriptional activation of Nrf2. J. Biol. Chem. 2005, 280:41921-41927.
27. Chen Z.H., Yoshida Y., Saito Y., Sekine A., Noguchi N., Niki E. Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-delta(12,14)-prostaglandin J2 through up-regulation of cellular glutathione via different mechanisms. J. Biol. Chem. 2006, 281:14440-14445.
28. Chen Z.H., Yoshida Y., Saito Y., Noguchi N., Niki E. Adaptive response induced by lipid peroxidation products in cell cultures. FEBS Lett. 2006, 580:479-483.
29. Saito Y., Nishio K., Numakawa Y., Ogawa Y., Yoshida Y., Noguchi N., Niki E. Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione. J. Neurochem. 2007, 102:1625-1634.
30. Huang Y., Li W., Kong A.N. Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal. Cell Biosci. 2012, 2:40.
31. Ohyama Y., Meaney S., Heverin M., Ekström L., Brafman A., Brafman A., Shafir M., Andersson U., Olin M., Eggertsen G., Diczfalusy U., Feinstein E., Björkhem I. Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatoryaxes. J. Biol. Chem. 2005, 281:3810-3820.
32. Lütjohann D., Breuer O., Ahlborg G., Nennesmo I., Sidén A., Diczfalusy U., Björkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24Shydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. USA 1996, 93:9799-9804.
33. Willy P.J., Umesono K., Ong E.S., Evans R.M., Heyman R.A., Mangelsdorf D.J. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 1995, 9:1033-1045.
34. Steffensen K.R., Neo S.Y., Stulnig T.M., Vega V.B., Rahman S.S., Schuster G.U., Gustafsson J.Å., Liu E.T. Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals. J. Mol. Endocrinol. 2004, 33:609-622.
35. Tall A.R., Yvan-Charvet L., Terasaka N., Pagler T., Wang N. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab. 2008, 7:365-375.
36. Terasaka N., Wang N., Yvan-Charvet L., Tall A.R. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc. Natl. Acad. Sci. USA 2007, 104:15093-15098.
37. Aye I.L., Waddell B.J., Mark P.J., Keelan J.A. Placental ABCA1 and ABCG1 transporters efflux cholesterol and protect trophoblasts from oxysterol induced toxicity. Biochim. Biophys. Acta 1801, 1013-1024:2010.
38. Matsuda A., Nagao K., Matsuo M., Kioka N., Ueda K. 24(S)-hydroxycholesterol is actively eliminated from neuronal cells by ABCA1. J. Neurochem. 2013, 126:93-101.
39. Tarling E.J., Edwards P.A. ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter. Proc. Natl. Acad. Sci. USA 2011, 108:19719-19724.
40. Berthier A., Lemaire-Ewing S., Prunet C., Monier S., Athias A., Bessède G., Pais de Barros J.P., Laubriet A., Gambert P., Lizard G., Néel D. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ. 2004, 11:897-905.
41. Royer M.C., Lemaire-Ewing S., Desrumaux C., Monier S., Pais de Barros J.P., Athias A., Néel D., Lagrost L. 7-ketocholesterol incorporation into sphingolipid/cholesterol-enriched (lipid raft) domains is impaired by vitamin E: a specific role for alpha-tocopherol with consequences on cell death. J. Biol. Chem. 2009, 284:15826-15834.
42. S.R. Freeman, X. Jin, J.J. Anzinger, Q. Xu, S. Purushothaman, M.B. Fessler, L. Addadi, H.S. Kruth, ABCG1-mediated generation of extracellular cholesterol microdomains. J. Lipid Res., 2013, in press. http://dx.doi.org/10.1194/jlr.M044552.
43. Xu P., Li D., Tang X., Bao X., Huang J., Tang Y., Yang Y., Xu H., Fan X. LXR agonists: new potential therapeutic drug for neurodegenerative diseases. Mol. Neurobiol. 2013, 48:715-728.